Five year follow-up of two sisters with type II sialidosis: systemic and ophthalmic findings including OCT analysis.

The authors report a 5-year follow-up examination of two sisters diagnosed as having a juvenile form of type II sialidosis. Diagnosis occurred during a routine ophthalmic examination when the girls were 5 and 3 years old after bilateral macular cherry-red spots were revealed. Main clinical findings were hypotonia, hepatosplenomegaly, hearing loss, dysostosis, and respiratory distress. Ophthalmic symptoms were low visual acuity and nystagmus. Spectral-domain optical coherence tomography examination showed increased reflectivity of the retinal ganglion cells. Sialidosis may present as a mild form with slow progression. The cherry-red spots may be the first clue for proper diagnosis of storage disease. Spectral-domain optical coherence tomography examination unveiled the accumulation of sialic acid in the retinal ganglion cells and could potentially be used to monitor the progression of storage diseases.

[1]  A. d’Azzo,et al.  Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease. , 2010, Biochemical Society transactions.

[2]  S. Grossi,et al.  Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients , 2009, Journal of Neurology.

[3]  C. Barr,et al.  Cherry red spot in sialidosis (mucolipidosis type I). , 2008, Archives of ophthalmology.

[4]  M. Fornerod,et al.  Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. , 1996, Genes & development.

[5]  S. Franceschetti,et al.  Sialidosis type I: pathological study in an adult. , 1989, Clinical neuropathology.

[6]  N. Tanaka,et al.  Liver glutathione S-transferase polymorphism in Japanese and its pharmacogenetic importance , 1987, Human Genetics.

[7]  T. Sasazuki,et al.  The patient with combined deficiency of neuraminidase and 21-hydroxylase , 1987, Human Genetics.

[8]  K. Hirokawa,et al.  Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia , 2009, Acta Neuropathologica.

[9]  B. Homer,et al.  Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis) , 1999, Acta Neuropathologica.